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Abstract
Physiological adaptations resulting in the development of the metabolic syn-
drome in man occur over a time span of several decades. This combined with
the prohibitive financial cost and ethical concerns to measure key metabolic
parameters repeatedly in subjects for the major part of their life span makes
that comprehensive longitudinal human data sets are virtually nonexistent.
While experimental mice are often used, little is known whether this species is
in fact an adequate model to better understand the mechanisms that drive the
metabolic syndrome in man. We took up the challenge to study the response
of male apoE*3-Leiden.CETP mice (with a humanized lipid profile) to a
high-fat high-cholesterol diet for 6 months. Study parameters include body
weight, food intake, plasma and liver lipids, hepatic transcriptome, VLDL –
triglyceride production and importantly the use of stable isotopes to measure
hepatic de novo lipogenesis, gluconeogenesis, and biliary/fecal sterol secretion
to assess metabolic fluxes. The key observations include (1) high inter-indivi-
dual variation; (2) a largely unaffected hepatic transcriptome at 2, 3, and
6 months; (3) a biphasic response curve of the main metabolic features over
time; and (4) maximum insulin resistance preceding dyslipidemia. The bipha-
sic response in plasma triglyceride and total cholesterol appears to mimic that
of men in cross-sectional studies. Combined, these observations suggest that
studies such as these can help to delineate the causes of metabolic derange-
ments in patients suffering from metabolic syndrome.
ª 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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Introduction
Physiologic adaptations resulting in the development of
the metabolic syndrome in man occur over a time span
of several decades. For example, central adiposity builds
up over a time-frame of years and decades (Reaven 1988;
Lebovitz and Banerji 2005). Furthermore, studies suggest
that parameters of the metabolic syndrome such as insu-
lin resistance, muscle mass, plasma triglycerides, and low-
density lipoprotein cholesterol (LDL-c) are age dependent
(Janssen et al. 2000; Murakata et al. 2015). Moreover, the
relation between these parameters and age appears non-
linear. A cross-sectional study in Japan showed biphasic
responses for body mass index, serum triglycerides and
LDL-c in men, but not for women (Murakata et al.
2015). Finally, a cross-sectional study performed in a pre-
dominantly Caucasian cohort showed nonlinear relation-
ship between age and skeletal muscle mass (Janssen et al.
2000). It is not clear why these age-associated changes
occur, but decreased physical activity and a decrease in
growth-hormone and gonadal hormones have been pro-
posed as possible explanations (Janssen et al. 2000; Mura-
kata et al. 2015). In contrast, insulin resistance appears to
only increase with increasing age (Muller et al. 2014). In
any case, time is an important factor, and a longitudinal
setup should therefore be preferred above a cross-sec-
tional setup to elucidate the mechanisms orchestrating
the metabolic syndrome.
Although scarce, some longitudinal studies of metabolic
syndrome in man have been performed. Scuteri et al.
(2009) found that triglycerides in men increased with
time, however, decreased in healthy men in the 65–
75 years age group, while in women triglycerides
increased in all age groups. Furthermore, Meigs et al.
(2003) found that increased fasting glucose does not nec-
essarily progress to diabetes when subjects are followed
up for over 10 years. Hamer et al. (2015) found that 45%
of subjects classified as being “healthy obese” progressed
to an unhealthy state (e.g., high triglycerides, impaired
glycemic control) compared with 16% of normal-weight
subjects over a period of 8 years. While these longitudinal
studies are very valuable, a major limitation is that (more
laborious) metabolic flux measurements (i.e., VLDL –
triglyceride [TG] production, sterol balance) have not
been carried out, and for obvious reasons such studies
can only sample a fraction of the human lifespan.
Animal models of metabolic syndrome allow for study-
ing metabolic alterations during development of the
metabolic syndrome in a shorter time-frame (Hariri and
Thibault 2010). However, translation is limited by spe-
cies-specific characteristics and responses to perturbations
designed to induce the metabolic syndrome (Hackam and
Redelmeier 2006). For example, the fact that mice have
very efficient clearance of triglyceride-rich lipoproteins
limits extrapolation to humans, who generally achieve
higher plasma TG concentrations (Van Vlijmen et al.
1998). Similarly, while mice carry most of their plasma
cholesterol in high-density lipoprotein (HDL), humans
have a large LDL-c fraction (Wang et al. 2011). To miti-
gate these species-specific differences, we make use of
“humanized” apoE*3-Leiden.CETP (E3L.CETP) mice, in
which the apoE*3-Leiden transgene confers reduced clear-
ance of triglyceride-rich lipoprotein (i.e., chylomicron-
and VLDL-remnants), and the cholesteryl ester transfer
protein (CETP) transgene further adds to a cholesterol
profile more closely resembling that of humans (Westert-
erp et al. 2006). Interestingly, in contrast to other mouse
models of atherosclerosis, the E3L.CETP mouse has been
shown to respond similar to treatment with statins,
fibrates, and ezetimibe as humans in terms of changes in
plasma cholesterol and atherosclerotic progression (Zade-
laar et al. 2007). Moreover, E3L.CETP mice respond simi-
lar to humans to antidiabetic drugs as well (van den
Hoek et al. 2014). However, whether E3L.CETP mice are
a good model to study the development of metabolic syn-
drome through time is unclear to date.
Here, we study whether male E3L.CETP mice are an
adequate model to study the metabolic syndrome in man,
by following their response to a high-fat high-cholesterol
diet (HFCD) for 6 months. We found that both dyslipi-
demia and parameters of insulin resistance followed a
biphasic trajectory. A biphasic trajectory in dyslipidemia
is also found in man during aging. These data indicate
that male E3L.CETP mice on HFCD may be an adequate
model to study the age-dependent changes of plasma
lipids in man.
Methods
Animals, diet, and housing
Male E3L.CETP mice (van den Maagdenberg et al. 1993;
Wang et al. 2011) were housed individually and fed a
synthetic HFCD diet containing 60% fat in energy and
0.25% cholesterol in weight (D12429, Research Diets) in
a light (lights on at 7:00 AM–lights off at 7:00 PM) and
temperature-controlled (21°C) facility. Prior to the start
of the experimental period, mice were co-housed with
siblings and fed chow ad libitum with unlimited access to
drinking water. At least 1 week prior to the start of the
experiment animals were housed individually to acclima-
tize. Experimental procedures were approved by the
Ethics Committees for Animal Experiments of the
University of Groningen.
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Experimental setup
Mice were fed a HFCD diet at the age of 4 months. Four
cohorts of mice were fed HFCD diet ad libitum for 4
(n = 20), 9 (n = 19), 13 (n = 20), and 28 weeks
(n = 30), respectively. At the end of the dietary interven-
tion, mice in the respective cohorts were distributed
evenly in two groups, where one group underwent mea-
suring of VLDL-TG production and the other group was
used for measuring hepatic de novo lipogenesis, for bile
cannulation and tissue collection. Animals were dis-
tributed among the two groups in the week of termina-
tion by placing every consecutive age-sorted mouse in a
different group. An additional cohort (n = 16) was used
specifically for measuring endogenous glucose production
at week 3, 9, 15, and 27 of the dietary intervention. These
animals also underwent either VLDL-TG production mea-
surement or bile cannulation and tissue collection. In all
groups, blood samples were obtained by tail bleeding at
4–6 week intervals, to determine plasma TG, plasma total
cholesterol (TC), HDL-c, and glucose. In addition, 24-h
feces were collected from all groups at 4–6 week interval.
All flux measurements and blood sample collections
started at 1 PM in the fasting condition, with food being
removed at 9 AM.
Drop outs
Of the 115 animals included in the study, in total 10 ani-
mals (2 in the 13 week cohort, and 8 in the respective
28 week cohorts) had to be terminated prematurely
because of rapid weight loss, which in seven cases coin-
cided with excessive grooming, scratching, and scratch
marks. No cause was found for the other three cases.
Data of these animals obtained prior to termination were
not excluded for analysis, since including or excluding
these measurements had virtually no effect on the mixed
models. Readers who wish to examine the difference in
modeling results may consult Table S1 and the corre-
sponding matlab scripts.
Plasma metabolite concentrations
Plasma TG was measured using a commercially available
kit (Roche Diagnostics). Plasma insulin was measured by
ELISA (Alpco). Glucose was measured on whole blood
using an Accu-Check glucose meter. Plasma TC and free
cholesterol were measured by a colorimetric assay accord-
ing to the CHOD-PAP method (Allain and Poon 1974).
HDL-c was measured by measuring total cholesterol in
the supernatant after precipitating apoB-containing
lipoproteins with polyethylene glycol 6000 (PEG6000)
(Izzo et al. 1981).
Hepatic metabolite concentrations
Liver lipids were extracted using a Bligh and Dyer (1959)
procedure. Liver lipids were then redissolved in 2% Triton-
X100 and measured using a commercially available kit for
measurement of triglyceride (Roche) and the CHOD-PAP
method for TC and free cholesterol measurement (Allain and
Poon 1974). Phospholipids after Bligh and Dyer extraction
were measured according to Bottcher et al. (1961).
RNAseq analysis
RNA was isolated using a commercially available kit
(RNeasy, Qiagen). Initial quality check and RNA quantifi-
cation of the samples was performed by capillary elec-
trophoresis using LabChip GX (Perkin Elmer).
Nondegraded RNAsamples were used for subsequent
sequencing analysis. Sequence libraries were generated
using the 30QuantSeq sample preparation kits (Lexogen).
The obtained cDNA fragment libraries were sequenced on
an Illumina HiSeq2500 using default parameters (single
read 1 9 50 bp) in pools of multiple samples. The
obtained fastQ files were aligned to build Mus_muscu-
lus.GRCm38 ensembleRelease 82 reference genome using
hisat/0.1.5-beta-goolf-1.7.20 (Dobin et al. 2013) with
default settings. Before gene quantification, SAMtools/1.2-
goolf-1.7.20 was used to sort the aligned reads (Li et al.
2009). The gene level quantification was performed by
HTSeq-count HTSeq/0.6.1p1 using –mode=union (Anders
et al. 2014). Analysis of gene expression was performed in
R (Law et al. 2016). Counts were normalized with the
trimmed-mean of M-value normalization (TMM) method
provided in the edgeR package (Robinson and Oshlack
2010). Analysis of differential gene expression was done
using voom transformation provided by the limma package
(Law et al. 2014). A false discovery rate of 0.05 and a log 2
fold change of 1 were taken as cutoff values for differen-
tially expressed genes. To account for a batch effect intro-
duced during RNA isolation, this was included in the
design of the linear model. For visualization of batch-con-
trolled gene expression, batch effect was removed using the
ComBat function of the R SVA-package (Leek et al. 2012).
Plots of gene expression in this article were produced by
making use of the R packages ggplot2 (Wickham 2011) and
superheat (Barter 2016).
Liver histology
Paraffin sections were stained with hematoxylin and eosin
stain and Sirius Red. The slides where then scored for
NASH according to Kleiner et al. (2005). The percentage
of fibrosis was determined as follows: Three x4 digital
images were obtained randomly from every section using
ª 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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the polarized light option. The three pictures covered
approximately between 70% and 90% of the specimen’s
total surface area. The images were imported to ImageJ
and subsequently analyzed using an in-house developed
macro which was written to quantify the area, percentage,
and integrated density of positively stained collagen fibers
in every image using a camera specification with
226.7 msec exposure, sensitivity set to ISO 200, and snap-
shot resolution of 2560 9 1920.
VLDL-TG production
Animals were injected intraperitoneally with poloxamer
407, an inhibitor of lipoprotein lipase, at a dose of
1000 mg/kg BW (Millar et al. 2005). After 30, 60 and
180 min, a small volume of blood was collected for the
measurement of triglycerides. VLDL-TG production was
then calculated by multiplying the slope of increased TG
concentration by the theoretical plasma volume based on
their body weight, where a blood volume of 75 mL/kg is
assumed with a hematocrit of 0.45.
Hepatic de novo lipogenesis
Animals were provided with drinking water containing
2% C13-acetate at 9 AM. Food was removed the following
day at 9 AM and animals sacrificed at 1 PM. Liver lipids
were isolated using the Bligh and Dyer procedure. Iso-
lated lipids were derivatized in acidic methanol at 90°C
for 4 h. Mass-isotopomer distribution of methylated fatty
acids was then measured by LC–MS. Hepatic de novo
lipogenesis and elongation was calculated as described
previously (Hellerstein et al. 1993; Hellerstein and Neese
1999; Oosterveer et al. 2009).
Endogenous glucose production
Endogenous glucose production was determined as
described previously with minor modifications (van Dijk
et al. 2013): Food was removed at 9 AM and the experi-
ment started at 1 PM. At 1 PM, animals received 0.1 mg/g
[6,6]-D2-glucose intraperitoneally at a concentration of
30 mg/mL. Immediately before, and 10, 20, 30, 40, 50, 60,
75, and 90 min after the intraperitoneal injection, a small
amount of blood was collected on a filter paper and glucose
measured with an Accu-Check glucose meter. Glucose
was then extracted from the dried blood with a water/etha-
nol mixture. After the solution was evaporated under nitro-
gen flow at 60°C, the residue was derivatized to glucose
penta-acetate by adding 100 lL pyridine and 200 lL acetic
anhydride to the extracted glucose and heating at 60°C for
30 min. After evaporation under nitrogen flow, the residue
was then dissolved in 200 lL ethyl acetate for analysis by
GC–MS. GC–MS was performed with a Zebron ZB-1701
30 m 9 250 lm 9 0.25 lm (Phenomenex) column under
positive chemical ionization with ammonia ions monitored
at m/z 408–412 (m0–m4). After corrections for natural
abundances according to Lee et al., the kinetics of the
enrichment of glucose with D2-glucose were then used to
estimate endogenous glucose production and related
parameters according to van Dijk et al. (2013).
Bile metabolite concentrations
Gallbladder cannulation was performed under fentanyl–
fluanisone anesthesia (1 mL/kg). After allowing the gall-
bladder to empty for 5 min, bile was collected for 20 min
while mice were placed in an incubator to maintain body
temperature. Bile production was measured by weighing
the collected bile. Quantification of biliary bile acids was
performed as follows. Bile samples were 10009 diluted
with MilliQ. After homogenization, 25 lL diluted bile was
aliquoted into a clean tube for bile acid analysis. For every
10 samples prepared, one quality control standard plasma
was included. To each sample 250 lL internal standard
solution was added and vortexed for 1 min. D4-cholic acid,
D4-chenodeoxycholic acid, D4-glycochenodeoxycholic
acid, D4-glycocholic acid, D4-taurochenodeoxy-cholic
acid, and D4-taurocholic acid were used as internal stan-
dards. Samples were then centrifuged at 15,800g and the
supernatant transferred to a clean glass tube. The fluid was
evaporated under nitrogen at 40°C. If samples were not
measured immediately, they were stored at 20°C until
further analysis. Samples were then reconstituted in 200 lL
50% methanol in water, vortexed for 1 min, and cen-
trifuged for 3 min at 1800g. The supernatant was trans-
ferred into a 0.2 lm spin-filter and centrifuged at 2,000g
for 10 min. After filtering, the samples were transferred
into LC–MS vials and analyzed (10 lL injection volume).
For separation, a Nexera X2 Ultra High Performance Liq-
uid Chromatography system (Shimadzu, Kyoto, Japan),
coupled to a SCIEX QTRAP 4500 MD triple quadrupole
mass spectrometer (SCIEX, Framingham, MA) (UHPLC-
MS/MS) was used, with an ACQUITY UPLC BEH C18
Column (1.7 lm 9 2.1 9 100 mm) equipped with a
ACQUITY UPLC BEH C18 VanGuard Pre-Column
(1.7 lm 9 2.1 9 5 mm) (Waters, Milford, MA). Separa-
tion was achieved in 28 min using 10 mmol/L ammonium
acetate in 20% acetonitrile (mobile phase A) and 10 mmol/
L ammonium acetate in 80% acetonitrile (mobile phase B),
total flow rate: 0.4 mL/min. To quantify biliary lipids,
lipids were isolated from 15 lL of bile using Bligh and
Dyer (1959) extraction and split in 10 lL for cholesterol
measurement via a homemade assay according to Gamble
et al. (1978) and 5 lL for phospholipid measurement
according to Bottcher et al. (1961).
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Feces metabolite concentrations
Neutral sterols and bile acids were measured by GC–MS
as described previously (van Meer et al. 2008), with a
minor modification, where fecal neutral sterols are
extracted from 50 mg of feces with 2 9 2 mL petroleum
ether after saponification in 1 mL of alkaline methanol,
instead of 3 9 3 mL.
Statistical analysis
While we aimed for a fully longitudinal study, some
parameters are currently not accessible for multiple mea-
surements in the same animal, since they require termi-
nating the animal. Such cross-sectional data between
different time points were compared with one-way
ANOVA, or when a non-parametric test was indicated, by
a Kruskal–Wallis test and the P-value adjusted for multi-
ple comparisons by Tukey–Kramer correction. For all
truly longitudinal data, mixed-linear effects models were
used to establish whether data were best described as
biphasic or as either linearly increasing or decreasing,
using the MATLAB and Statistics Toolbox Release 2015b
software. Values versus fitted-value plots were used to
check for the presence of heteroscedasticity and non-nor-
mal distribution of the residuals. When the model was
best described as biphasic, best linear unbiased estimates
were used to calculate the peak of the fitted model. To
calculate marginal and conditional R2, we made use of
the formulas described by Johnson (2014).
marginalR2 ¼ varfixed=ðvarfixedþ varrandom
þ varresidÞ
conditionalR2 ¼ ðvarfixedþ varrandomÞ=ðvarfixed
þ varrandomþ varresidÞ
In the setting of a mixed-effect model, the marginal R2
reflects the variation explained by the fixed-effects of the
linear model. In our case, by using time as the only vari-
able, it reflects how much of the variation is explained by
the coefficients that fit the group mean response through
time. The conditional R2, in contrast, reflects how much
of the variation in time is explained when including the
individual response to the diet. That is, when allowing
coefficients for individual mice to be normally distributed
around the estimate for the group mean response.
Results
Body weight and food intake
Body weight rapidly increased in response to the HFCD
and then plateaued around 12–16 weeks (Fig. 1). Mixed
modeling suggests a maximum at 18 weeks, with a mar-
ginal and conditional R2 of 0.47 and 0.98, respectively,
illustrating the large variation in body weight between
animals. Food intake was higher the first few weeks after
introduction to the diet. Toward the end of the diet some
animals showed increased food intake as well. We note
that food intake is difficult to determine accurately, as the
food pellets are crumbly and some animals are prone to
spillage, especially immediately after introduction to the
diet (Fig. S1). When applying a mixed model to the food
intake, we find a better fit for a biphasic curve where the
marginal response indicates a minimum at 13 weeks with
a week-averaged daily food intake of 3.2 g and a daily
food intake of 3.7 and 3.8 g at the start and end of the
experiment, respectively. These results should be inter-
preted with caution since the marginal R2 is only 0.03.
Median daily food intake was 3.1, 3.2, 3.3, and 3.2 g for
the 4, 9, 13, and 28 week cohorts, respectively. We noted
that individual median food intake correlated with maxi-
mum body weight attained for the 9, 13 and 28 week
cohort (Fig. 2) but not for the 4 week cohort. The corre-
lations of the 28 week cohort are only significant when
drop outs are excluded. All in all, these results indicate
that at least part of the variation in body weight observed
may be explained by individual differences in food intake.
Plasma lipid parameters
Plasma triglyceride (Fig. 3A) and plasma total cholesterol
(Fig. 3B) showed considerable changes and an interesting
biphasic response to the HFCD. Inspection of the data in
















Figure 1. Body Weights of male E3L.CETP mice on HFCD over
time. Note that body weight plateaus around 12–15 weeks. Blue-
dotted lines represents the group mean response of the mixed
model. Red lines connect measurements performed on the same
individual animal. Mixed modeling suggests a maximum at
18 weeks HFCD.
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Fig. 3 suggests a maximum in plasma triglyceride and
cholesterol between 16 and 20 weeks after start of the
diet. To test and quantify these observations, mixed linear
effect models were used. Using time as the sole predictor
variable, we found that for plasma triglyceride and total
cholesterol model specifications with third power and
quadratic fixed effects, respectively achieved a better fit to
the data than the corresponding mixed effect models with
time as a linear predictor. This supports that the observed
response in plasma triglyceride and total cholesterol is
indeed biphasic. Plasma TG was transformed by taking
the square root to mitigate heteroscedasticity in the resid-
uals. We found a marginal and conditional R2 of 0.19
and 0.9 for plasma triglyceride and 0.50 and 0.87 for
plasma total cholesterol, underlining that the random
effects (i.e., individual contribution) explain a large pro-
portion of the variance. The terms of the fixed effects
point to a maximum at 18 weeks for both plasma triglyc-
eride and total cholesterol. Inspection of the HDL-c data
does not convey a clear trend through time (Fig. 3C).
However, similar to plasma TG, mixed modeling results
in the best data fit for third power model, leading to a
marginal and conditional R2 of 0.14 and 0.57, respectively
and a maximum at 9 weeks. Consistent with the findings
for plasma TC, mixed modeling of non-HDL-c shows a
maximum at 20 weeks, with a marginal and conditional
R2 of 0.51 and 0.83, respectively (Fig. 3D).
Plasma glucose and insulin
In line with effects on TG and cholesterol levels, plasma
glucose and insulin also reveal a biphasic response
(Fig. 4), yet the response peaked much earlier and was
apparently not directly coupled to changes in lipids.
Mixed modeling shows that for both glucose and insulin
a third power mixed effect model fits the data best, with
a peak for glucose at 6 weeks and a peak for insulin at
10 weeks. Marginal and conditional R2 for plasma glucose
and insulin were 0.18 and 0.28, and 0.28 and 0.8,
respectively.
Liver lipid content
Liver weight increased with the time spent on the HFCD
(Fig. 5A). There appears a trend for liver TG to first
increase and then decrease. However, even the most
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Figure 2. Correlations between individual median food intake over time with the maximally attained body weight of the respective cohorts.
Red points indicate animals that dropped out before the end of the experimental period. Pearson correlations shown are with dropouts
excluded. When including dropouts correlations are q = 0.62 (P = 0.0037) and q = 0.24 (P = 0.10) for the 13 and 28 weeks cohort,
respectively.
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marked difference in liver TG between 13 weeks and
28 weeks does not reach statistical significance
(P = 0.053) (Fig. 5B). Similarly, liver total cholesterol fol-
lows the trend of liver triglycerides (Fig. 5C). One-way
ANOVA shows no significant differences. Liver free
cholesterol remains constant through time, with a trend
for an increased free cholesterol concentration at the lat-
est time point (Fig. 5D). One-way ANOVA shows that
the difference between 28 weeks and both 4 (P = 0.01)
and 9 weeks (P = 0.02) were statistically significant. In
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Figure 3. Plasma triglyceride (A), total cholesterol (B), HDL-C (C) and non-HDLC (D), for male apoE*3L.CETP mice as measured at the indicated
time points. Data for the respective cohorts was pooled when measured on the same time point. Blue-dotted lines represents the group mean
response of the mixed model. Red lines connect measurements performed on the same individual animal.






























Figure 4. Whole blood glucose (A) and plasma insulin (B) of male apoE*3L.CETP mice as measured at the indicated time points. Data for the
respective cohorts was pooled when measured on the same time point. Blue-dotted lines represents the group mean response of the mixed
model. Red lines connect measurements performed on the same individual animal. Note the biphasic response and that glucose peaks earlier
than plasma insulin levels.
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contrast, liver phospholipids show a trend for being
decreased at the last time point when compared with the
first time point (Fig. 5E). One-way ANOVA shows that
the liver phospholipid concentrations after 4 weeks HFCD
differed significantly from 9 weeks (P = 0.01), 13 weeks
(P = 0.04), and 28 weeks (P = 0.02).

















































































































Figure 5. Liver weights (A), liver triglyceride (B), total cholesterol (C), free cholesterol (D) and phospholipid (E) concentrations, and NASH scores
(F) and fibrotic area (G) of livers in male apoE*3L.CETP cohorts sacrificed after 4, 9, 13, and 28 weeks HFCD, respectively. NASH scores show a
statistically significant difference both between 4 weeks and 13 (P = 0.047) and 28 weeks (P < 0.01) and between 9 weeks and 28 weeks
(P < 0.01), using the one-way Kruskal–Wallis test. Fibrotic area was remarkably similar for the cohorts sacrificed up to 13 weeks while fibrotic
area after 28 weeks HFCD diet was notably increased (P < 0.01). N = 10, 10, 9 and 21 for 4, 9, 13, and 28 weeks HFCD diet, respectively.
Significant differences are denoted with brackets and asterisks: P < 0.05 (*), P < 0.01 (**), P < 0.001 (***).
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Liver NASH scores
Liver NASH scores and fibrotic area increased with time
spent on HFCD (Fig. 5F–G). NASH scores show a statis-
tically significant difference both between 4 weeks and 13
(P = 0.047) and 28 weeks (P < 0.01) and between
9 weeks and 28 weeks (P < 0.01), using the one-way
Kruskal–Wallis test. Fibrotic area was remarkably similar
for the first 3 months while fibrotic area after 28 weeks
HFCD was notably increased (P < 0.01).
RNAseq analysis
To investigate the effect of 6 months HFCD feeding on
gene expression in the metabolic networks of the mice,
we determined global mRNA levels in the livers using
the Lexogen platform. The number of differentially
expressed genes after 9 weeks, 13 weeks, and 28 weeks
HFCD diet (compared with 4 weeks HFCD) was surpris-
ingly low; 1, 63 and 159, respectively, against 6843 genes
with sufficient sequencing depth. Of differentially
expressed genes, many were associated with inflamma-
tion and fibrosis and increased in expression over time.
For example, the collagen subunits Col1a1, Col1a2,
Col3a1, Col6a3 and the chemokines Ccl6, Cxcr4 were all
increased in expression at 13 weeks and 28 weeks
HFCD. Furthermore, we note high expression of glu-
tathion transferases (Gstm1, Gstm3) and galectins (Lgal-
s1, Lgals3) at 13 and 28 weeks of HFCD. When focusing
on differentially expressed genes with roles in metabo-
lism we note the following. G6pc expression was
increased (logFC = 1.4, FDR = 0.04) in the 9 weeks
HFCD cohort, Lpl expression was increased in the
13 week cohort (logFC = 1.4, FDR < 0.001) and 28 week
cohorts (logFC = 1.9, FDR < 1e-6), Pltp expression was
increased in the week 13 cohort (logFC = 1,
FDR < 0.001) and at 28 weeks HFCD (logFC = 1.1,
FDR < 1e-5), while Cyp7b1 (logFC = 1.5, FDR < 1e-6),
Cyp8b1 (logFC = 1.5, FDR < 1e-6), and Slc10A1
(logFC = 1.3, FDR < 1e-6) expression was decreased
after 28 weeks HFCD. Although it may be expected that
many genes important in the regulation of cholesterol
homeostasis (Nr1 h3, Nr1 h2, Nr5a2, Srebf2, Insig, Scap,
Hmgcr, Abcg5, Abcg8) and of triglyceride synthesis
(Srebf1, Fasn, Dgat2, Acly, Acaca, Acacb, Scd1, Gpd1)
would be differentially expressed over time, this was
actually not the case. A heat map is provided with the
genes mentioned above (Fig. 6), a full list of differen-
tially expressed genes over time may be found in a sup-
plemental file (Suppl. File RNA_analysis).
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Figure 6. Heatmap of selected gene expressions over time.
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VLDL-TG production and hepatic de novo
lipogenesis
In spite of both liver lipid content and histology showing
large changes over time, we found no differences in
VLDL-TG production. VLDL-TG production was 162
(46), 176 (29), 151 (44) and 136 (54) lmol TG/kg/h for
4, 9, 13 and 28 weeks, respectively (SDs are given within
brackets), thus showing no clear trend over time (Fig. 7).
Fractional de novo lipogenesis (i.e., the percentage of
newly synthesized fatty acids) appears higher at 13 and
28 weeks, with significant differences between 4 and
9 weeks on one hand and 13 and 28 weeks on the other
hand for de novo production of palmitate (C16:0,
Fig. 8A) and stearate (C18:0, Fig. 8B). Oleate (C18:1,
Fig. 8C) fractional de novo lipogenesis was also signifi-
cantly different between 9 weeks compared with 13 and
28 weeks. Fractional de novo lipogenesis attributable to
chain elongation of palmitate (Fig. 8D–E) shows a mixed
picture, with stearate contribution of chain elongation
being different only between 9 weeks and the 4, 13, and
28 week time points, whereas the oleate contribution to
chain elongation showed significant differences between 4
and 28 weeks.
Endogenous glucose production
Tracer kinetics showed a trend for decreasing AUC and
mean residence time over time, whereas for bioavailabil-
ity, apparent volume of distribution, metabolic clearance
rate, and glucose pool size the parameters decreased from
3 to 15 weeks HFCD followed by an increase at the 27-
week time point (Fig. S3). Similarly, and in line with the
decreasing trend for plasma glucose and the behavior of
the metabolic clearance rate with time spent on the
HFCD (Fig. 9A), it was seen that endogenous glucose
production decreased over time during the first 3 months,
followed by an increase toward 27 weeks of HFCD
(Fig. 9B). We observed no trend for overall insulin sensi-
tivity (Fig. 9D). However, peripheral insulin sensitivity
showed a decrease with a minimum around 9 weeks fol-
lowed by an increase towards 27 weeks. In contrast, the
hepatic insulin sensitivity showed a very mixed picture,
with values diverging the most at 9 weeks HFCD and
then converging slightly at 27 weeks HFCD. Mixed mod-
eling suggests a minimum of endogenous glucose produc-
tion at 17 weeks of HFCD. Marginal and conditional R2
were 0.53 and 0.53, respectively. Peripheral insulin sensi-
tivity showed a minimum at 15 weeks and marginal and
conditional R2 of 0.16 and 0.47, respectively.
Biliary bile acid and cholesterol secretion
In line with the biphasic curve observed for plasma and
liver lipids, biliary bile acid production, cholesterol pro-
duction, and phospholipid production also show a bipha-
sic trend (Fig. 10). One-way ANOVA shows that
differences over time for bile acid production do not
reach statistical significance. Biliary cholesterol production
is different between 9 and 13 weeks (P < 0.001), and
28 weeks (P = 0.03). Biliary phospholipid production is
also different between 9 and 13 (P = 0.002) on one hand
and between 13 and 28 weeks (P = 0.04) on the other
hand.
Fecal neutral sterol and bile acid excretion
Fecal neutral sterol excretion appears to increase with
time. In contrast, fecal bile acid excretion does not show
an obvious trend over time (Fig. 11). Mixed linear mod-
eling indicates, however, that in both cases a quadratic
model is appropriate. We then arrive at a minimum of
fecal neutral sterol excretion at minus 4 weeks, indicating
that the group mean response only increases in the exper-
imental time-frame, and a minimum of bile acid produc-
tion at 9 weeks. Marginal and conditional R2 for fecal
cholesterol excretion was found to be 0.18 and 0.75,
respectively, whereas marginal and conditional R2 for
fecal bile acid production was 0.02 and 0.69, respectively.
Clearly, there is a large individual contribution to varia-
tion in fecal sterol excretion.
Discussion
ApoE*3L.CETP mice fed an HFCD show a biphasic
course for plasma TG, TC, HDL-c, glucose, insulin,

















Figure 7. VLDL-TG production in the respective cohorts does not
convey a clear up or downward trend. One-way ANOVA shows no
significant differences between the time points. N = 10, 9, 9 and
16 for 4, 9, 13, and 28 weeks HFCD diet, respectively.
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endogenous glucose production and peripheral insulin
sensitivity, which at least for the changes in plasma lipids,
is reminiscent of similar observations in cross-sectional
studies in man. At the same time we must note that the
response of animals to the HFCD is extremely heterogenic
for which the reasons are not known. We further found
no change in VLDL-TG production between the different
time points. This indicates that differences in plasma
lipids over time are likely the result of changes in clear-
ance. Another interesting observation was that plasma
insulin peaked before plasma TG peaked, which suggests
that these two hallmarks of metabolic syndrome are not
similarly linked to body weight gain over time.
Inter-individual variation in response to
HFCD is large in E3L.CETP mice
A large degree of inter-individual variation was observed
in this study. The mouse strain used here, E3L.CETP and
the related apoE*3-Leiden strain, are known for their
heterogeneity in response to Western-type diets. In fact,
animals that do not respond to a diet containing 16% fat
and 0.1–0.25% cholesterol with respect to a sufficient
raise in TC are usually excluded from subsequent studies
on atherosclerosis development. While we cannot cur-
rently explain the heterogeneity, the observation that
median food intake correlated with the maximum
attained body weight, suggests that part of the observed
heterogeneity may be attributed to individual differences
in food intake. Furthermore, it should be noted that phe-
notypic heterogeneity is also observed in its background
strain C57BL/6J, and therefore not solely attributable to
the transgenes in E3L.CETP. C57BL/6J non-uniform
response to high-fat diets have been brought to the atten-
tion before, and has prompted researchers to stratify indi-
viduals for subsequent study (Burcelin et al. 2002; Peyot
et al. 2010). In fact, homozygosity in inbred mice has
long been known to increase variability (Phelan and Aus-
tad 1994).
Biphasic response in plasma insulin and
peripheral insulin sensitivity
We found that plasma insulin increases on HFCD and
peaks early, while notably peripheral insulin sensitivity, as
derived from stable-isotope tracer studies, increased over
time after an initial decrease. The majority of studies in
mice find increased insulin resistance with age on high-fat




















































































Figure 8. Fractional de novo lipogenesis for palmitate (C16:0) (A), stearate (C18:0) (B), oleate (C18:1) (C), and chain elongation of palmitate
to stearate (C18:0) (D) and to oleate (C18:1) (E), across the respective cohorts. N = 10, 9, 10 and 17 for 4, 9, 13 and 28 weeks HFCD diet,
respectively. Significant differences, according to one-way ANOVA, are denoted with brackets and asterisks: P < 0.05 (*), P < 0.01 (**),
P < 0.001 (***). [Correction added on 12 January 2018, after first online publication: Figure 8 has been replaced to match the figure legend]
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diet (Kleemann et al. 2010). However, decreasing insulin
resistance with age beyond 24 weeks of high-fat diet has
also been observed in C57BL/6J-mice (Van Der Heijden
et al. 2015). Cross-sectional studies in humans show that
insulin resistance increases with age (Janssen et al. 2000;
Dubowitz et al. 2014; Murakata et al. 2015). In our study
overall insulin sensitivity did not change while peripheral
insulin sensitivity increased in the second phase, indicat-
ing that E3L.CETP mice on HFCD do not behave similar
to humans with regard to changes in insulin resistance
beyond approximately 4 months of HFCD. It is unclear
what caused the increased peripheral insulin sensitivity in
this study and whether this finding is specific for this
mouse strain or a more general phenomenon of mice
subjected to HFCD for longer periods of time. Assuming
the latter, a potential mechanism may be that over the
course of the HFCD, cholesterol and oxysterol metabolites
accumulate in adipose tissue and lead to increased activa-
tion of NR1H3 (a.k.a. LXR), in turn leading to increased
peripheral insulin sensitivity (Baranowski 2008).
Biphasic response in dyslipidemia
reminiscent of decrease in plasma TG in
mouse models of accelerated aging
We observed a biphasic response in dyslipidemia to
HFCD with plasma TG and TC. Data regarding the devel-
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Figure 9. Steady state glucose (A), post-test plasma insulin (B), endogenous glucose production rate (C) of male E3L.CETP mice on HFCD.
From these values we can calculate insulin sensitivity (D), peripheral insulin sensitivity (E) and hepatic insulin sensitivity (F). Note that peripheral
insulin resistance decreases and increases over time while hepatic insulin resistance does not. Blue-dotted lines represents the group mean
response of the mixed model. Red lines connect measurements performed on the same individual animal. n = 16, 16, 15 and 14 for 3, 9, 15
and 27 weeks, respectively. [Correction added on 12 January 2018, after first online publication: Figure 9 has been replaced to match the
figure legend]
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over an extended time period have not previously been
reported. However, a longitudinal study in apoE3*Leiden
mice on a high-fat diet without added cholesterol up to
3 months showed a gradual increase in plasma TG and
plasma TC, which is in agreement with the current study
(Kleemann et al. 2010). Interestingly, plasma TG in the
Ercc1/D mouse model of accelerated aging at 21 weeks of
age is similar to wild-type mice aged 26–34 months, and
decreased compared to 7-week-old wild-type mice (Gregg
et al. 2012). In other words, a decrease in plasma TG in
mice is associated with aging, and the observed changes
in lipoprotein metabolism of E3L.CETP mice on HFCD
may share some mechanisms with those active in the
aging process.
VLDL-TG production does not explain
biphasic pattern of dyslipidemia
In this study, VLDL-TG production was not significantly
different between measured time points, suggesting that
the differences observed in dyslipidemia are likely due to
differences in the clearance of apoB-lipoproteins. In con-
trast, earlier studies in apoE3*Leiden mice on a HFCD
showed increased VLDL-TG production leading to a peak
at 45 days compared to 100 days of age (van Vlijmen
et al. 1996). In our experiment, however, animals were
aged >100 days at the start of the experiment. Together
these findings suggest that VLDL-TG production in
apoE3*Leiden and E3L.CETP mice are increased at a




































Figure 11. Fecal neutral sterol (NS) and bile acid excretion in male E3L.CETP mice on HFCD diet at 3 weeks (n = 30), 6 weeks (n = 16),
9 weeks (n = 30), 10 weeks (n = 16), 13 weeks (n = 30), 16 weeks (n = 15), 17 weeks (n = 29), 21 weeks (n = 29), 22 weeks (n = 14),
27 weeks (n = 24) and 28 weeks (n = 14). The blue-dotted line represents the group mean response of the mixed model. Red lines connect
measurements performed on the same individual animal.
































































Figure 10. Biliary bile acids (A), biliary neutral sterol (B) and biliary phospholipid secretion rate (C) in male E3L.CETP mice on HFCD diet for
4 weeks (n = 10), 9 weeks (n = 10), 13 weeks, (n = 9), or 28 weeks (n = 16), respectively.
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younger age on a HFCD, however, may decrease and sta-
bilize to a steady value once animals reach maturity.
Given that VLDL-TG production was not changed over
time, the observed changes in plasma TG are likely to be
the result of changes in triglyceride hydrolysis activity.
VLDL-TG production as primary cause for variation in
plasma TG can, however, not be completely excluded,
given the heterogeneity observed between animals and
that with the currently available methods, VLDL-TG pro-
duction in an animal can be measured only once. How-
ever, the fact that we observed no correlation between
basal plasma TG and VLDL-TG production rate (Fig. S4)
argues against this possibility.
Contribution of VLDL-production and
clearance to dyslipidemia in humans
Since E3L.CETP mice have a “humanized” lipoprotein
metabolism, it is of interest to compare findings in lipid
parameters of this study to those found in humans.
Whereas in this study differences in dyslipidemia appear to
be mediated by differences in lipoprotein clearance, dyslipi-
demia observed in metabolic syndrome in men is consid-
ered to be caused by an increase in VLDL-production
(Adiels et al. 2008). Furthermore, increased age is associ-
ated with increased VLDL-production as well as reduced
LDL-clearance in men (Millar et al. 1995). On the other
hand, studies in women and mixed groups suggest that
age-related increases in triglycerides and cholesterol are
due to decreased catabolism of lipoproteins (Pinto et al.
2001; Matthan et al. 2005). All in all, we must conclude
that in humans both VLDL-TG production and clearance
can contribute to differences in plasma TG. Although a
limitation of this study was that triglyceride hydrolysis
activity as such was not evaluated, the lack of significant
differences in VLDL-TG production over time suggests that
changes in triglyceride hydrolysis activity was the predomi-
nant factor in the dyslipidemia observed here.
Gene expression profiles do not follow the
response to HFCD in metabolic fluxes
Gene expression analysis of E3L.CETP mice on HFCD for
4, 9, 13, and 28 weeks showed an increase in expression of
genes involved in inflammation and fibrosis. Furthermore,
we observed that metabolic differentially expressed genes
encoding metabolic enzymes showed little correlation with
the measured metabolic fluxes. First, the increased G6pc
expression after 2 months HFCD does not coincide with
increased endogenous glucose production. It should be
noted that G6pc expression is mostly linked to increased
glucose production in primary hepatocytes, whereas
in vivo studies show that changes in G6pc expression do
not necessarily result in changes in endogenous glucose
production (Van Dijk et al. 2001; Doi et al. 2007). Sec-
ondly, a decrease in Cyp7b1, Cyp8b1, and Slc10a1 in
expression over time, does not coincide with a concomi-
tant decrease in biliary bile acid secretion. This is in agree-
ment with earlier findings where changes in bile acid gene
expression may affect composition of bile acids but has lit-
tle bearing on the total biliary bile acid secretion (Sokolo-
vic et al. 2010; Boesjes et al. 2014). Finally, absence of Pltp
has previously been shown to impair VLDL-TG produc-
tion in mice (Yazdanyar and Jiang 2012). Here, we
observed that Pltp was decreased in expression over time,
with, however, no changes in VLDL-TG production. Over-
all, the findings in this study may serve as another remin-
der that gene expression can generally be considered as a
poor predictor of metabolic fluxes (Daran-Lapujade et al.
2007; Morandini 2009, 2013).
Linear relation between body weight and
liver weight
While the liver weight increased over time, hardly any
significant changes through time on HFCD for the liver
lipids were observed. Free cholesterol, however, increased
with time, which is in line with other studies, in which
free cholesterol accumulates in the liver on high-fat high-
cholesterol diet and contributes to NASH development
(Van Rooyen et al. 2011). Interestingly, we furthermore
observed a near linear relation between body weight and
liver weight, suggesting a redistribution of fat from adi-
pose tissue to liver. In contrast, the relation between body
weight and liver triglyceride concentrations is less clear.
Modest increase in hepatic de novo
lipogenesis over time
Changes in hepatic de novo lipogenesis were more evi-
dent, being increased at 13 and 28 weeks HFCD com-
pared with 4 and 9 weeks time points. This is in line with
other mouse studies where high-fat diet stimulated hep-
atic de novo lipogenesis and this effect was stronger with
longer time spent on high-fat diet (Pierce et al. 2016). In
human studies, the relation between age and hepatic de
novo lipogenesis has received little attention to date, with
one study reporting increased hepatic de novo lipogenesis
in elderly compared to younger controls (Flannery et al.
2012). Furthermore studies are necessary to establish these
relations.
Biliary bile acid and cholesterol fluxes
We observed no clear pattern in biliary bile acid secretion
over time. Dietary cholesterol increases bile acid
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production in mice within 3 weeks (Jolley et al. 2000).
On the other hand, aging has been reported to decrease
bile acid production in both the humans and mice
(Einarsson et al. 1985; Wang 2002). In contrast, biliary
cholesterol production increases with age in man (Einars-
son et al. 1985). While we observed an increase in biliary
cholesterol production between 28 weeks and 9 weeks,
the difference between 28 weeks and 4 weeks HFCD was
not statistically significant. All in all, there appears to be
no aging effect in bile production in E3L.CETP mice on
HFCD within 28 weeks.
Role of cholesterol absorption in
dyslipidemia in mice and humans
Dyslipidemia in mice is generally elicited through feed-
ing HFCD, since high-fat diet without added cholesterol
is not sufficient (Kleemann et al. 2007). It follows that
cholesterol absorption may be an important factor in
the response to the HFCD. Here, we found that fecal
neutral sterol excretion increased with time on HFCD,
indicating that dietary cholesterol absorption of
E3L.CETP mice on HFCD decreases as mice age. Of
note, C57BL/6J-mice on a standard diet show the oppo-
site, that is, an increase in cholesterol absorption with
increasing age (Duan et al. 2006). In humans, cholesterol
absorption is an important predictor for dyslipidemia
(Matthan et al. 2009; Cederberg et al. 2013). Moreover,
a cross-sectional study in Finland found that healthy 75-
year-old men show decreased cholesterol absorption
compared with 50-year-old men (Gylling et al. 1994).
Taken together, it appears that E3L.CETP mice on a
HFCD follow a similar trajectory in cholesterol absorp-
tion as humans. While at this point it is not clear
whether these observations are caused by comparable
mechanisms, it is intriguing that a “humanized” lipid
profile may also lead to a “human” trajectory in intesti-
nal cholesterol absorption.
Insulin resistance precedes dyslipidemia
We observed in this study that insulin resistance pre-
ceded dyslipidemia. Similar observations have been
made in other animal as well as human studies. Bar-
nard et al. observed that first fasting insulin levels
increased, that is, within 2 weeks, and then plasma TG
increased in unison with glycerol release and fat cell
size in female Fischer rats on high-fat high-sucrose diet
(Barnard et al. 1998). Similarly, in the San Antonio
Heart Study, fasting plasma insulin was shown to be
predictive for increased plasma TG at 8 years follow-up
in humans (Haffner et al. 1992; Mitchell et al. 1992).
Assuming that a common cause for insulin resistance
and dyslipidemia exists, these findings imply that insu-
lin resistance is triggered first and dyslipidemia only
occurs beyond a threshold. The idea of a threshold is
consistent with the paradigm of insulin resistance being
caused by free fatty acids leaking into the system once
the capacity of white adipose tissue to store fat is
exceeded. Recently, van Beek et al. (2015) found that in
C57Bl/6J mice, plasma TG increases sharply once mice
exceed a body weight around 40 g. While here a simi-
lar pattern is observed (Fig. S5), the variation is higher,
suggesting the presence of another factor that modu-
lates plasma TG. Similarly, while van Beek et al. (2015)
find a close relationship between body weight and
plasma insulin, here we find that this relationship is
less distinct, and that body weight in the first 3 months
of HFCD is associated with higher plasma insulin levels
than in the second 3 months of HFCD (Fig. S5). This
change in relation between body weight and both insu-
lin resistance and dyslipidemia implies that, if fatty
acids are considered the culprit, a fatty acid sink must
develop over time, mitigating both dyslipidemia and
insulin resistance.
In conclusion
Overall, E3L.CETP mice on a HFCD show a biphasic
response in metabolic parameters through time, and may
prove to be an adequate model to study age-dependent
changes in plasma lipids in men.
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Figure S1. Food intake of E3L.CETP – mice on HFCD
diet through time.
Figure S2. Liver weight correlates with body weight (q =
0.9, P > 0.001).
Figure S3. Tracer kinetics of male E3L.CETP mice that
were used to measure endogenous glucose production:
Mean residence time (A), Bioavailibility (B), AUC (C),
apparent volume of distribution (D), metabolic clearance
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VLDL-TG production was observed (rho =-0.08, P
=0.59).
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